Endpoints News 生物医药· Max Gelman·· 2026-10-12AI 评分60
Bristol Myers Squibb 两项 III 期研究成功,涉及 RayzeBio 药物
Bristol Myers reveals a pair of Phase 3 wins for fibrosis, RayzeBio drugs
AI 导读
Bristol Myers Squibb 周一报告两项 III 期研究成功,其中一项涉及近期出现安全性问题的在研药物,涉及 RayzeBio 药物。原文正文未提供药名、适应症、具体终点或数值。
正文
Bristol Myers Squibb reported two Phase 3 successes on Monday morning, including for an experimental drug that recently ran into safety issues.
A trial testing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news